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Background: Dengue virus infection manifests in three distinct forms in humans: dengue fever, dengue hemorrhagic
fever, and dengue shock syndrome. Infection with the virus is a fatal disease; no vaccine is available and prevention
depends on interruption of the chain of transmission. The study of dengue viral transmission by mosquitoes is
hindered due to the lack of an affordable animal model. In general, immuno-competent mice are used as a simple and
inexpensive animal model, but mice are not susceptible to dengue virus infection and therefore viremia will not
occur following the inoculation of the virus in such mice. Here, we report a method for creating artificial viremia
in immuno-competent mice, and further demonstrate the use of viremic mice to simultaneously infect a large
number of Aedes aegypti.
Methods: We infected K562 cells with DENV-2 in the presence of an antibody against DENV-4. We then incubated the
cells for 2 d before injecting the infected cells into C3H mice. After 5 h incubation, we allowed 100–150 female Aedes
aegypti to feed on blood from the mice directly. We collected blood samples from the mice and from randomly
selected Ae. aegypti at 2, 6, 12, and 24 h post-blood meal and screened the samples for DENV-2 genome as well as
for virus concentration.
Results: Our procedure provided high virus concentrations in the mice for at least 7 h after viral inoculation. We found
that 13 out of 14 randomly picked mosquitoes were infected with DENV-2. High concentrations of virus were detected
in the mosquitoes until at least 12 h post-infection.
Conclusions: Using the viremic immuno-competent mouse, we show that mass infection of Ae. aegypti is achievable.
Compared to other infection techniques using direct inoculation, membrane-feeding, or immuno-deficient/humanized
mice, we are confident that this method will provide a simpler and more efficient infection technique.
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Dengue virus (DENV) is among the deadliest arthropod-
borne disease in the world. The virus causes dengue fever
and its more severe forms, dengue hemorrhagic fever and
dengue shock syndrome. The disease has a global distribu-
tion, with South East Asia and Western Pacific regions
carrying 75% of the current global disease burden [1]. In
endemic areas, cases are reported year-round, with a
surge of incidence observed during intervals of increased
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increase in range of habitat. The close proximity of the
DENV vector to human populations permits easy trans-
mission of the virus from one infected person to another
[2]. Disease control is complicated by the fact that no
vaccines or specific medicines are available for preven-
tion or treatment of the disease. Hence, DENV poses an
imminent danger that can seriously compromise public
health in heavily populated tropical urban areas. It is
complicated by the poorly understood factors of hyper-
endemic, community, and inter-annual transmission
[3]. However, characterization of these factors and their
relative importance on transmission has been complicatedntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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transmission [4].
Understanding dengue transmission has always been
difficult due to the lack of animal models. Viremia is a
feature required in a dengue-vector transmission experi-
ments. The minimum virus concentration needed to cause
infection in mosquitoes has not been formally defined.
Previous reports indicated that doses of 4 × 104 PFU/ml
(in chick-skin membrane) [5] and 5 × 104 PFU/ml (intra-
venous injection in adult rhesus monkey) [6] sufficed
for transmission, suggesting that concentrations of approxi-
mately 104 PFU/ml represent a lower limit for effective
infection in mosquitoes. This minimum dose is achievable
by only three naturally occurring hosts that can naturally
amplify DENV: mosquitoes, humans, and non-human pri-
mates (NHP) [7]. NHP, including the common marmoset,
can develop viremia that manifests as very mild or no
clinical signs of disease [8,9]. However, research using
NHP remains a challenge for many researchers, given the
high cost and limited accessibility of such models [10].
Furthermore, the utilization of NHP for transmission
experiments might be considered a waste of resources.
Non-costly and easily accessible animals are preferable
for such experiments.
Mice are generally considered the animal of choice for
many experiments due to the fact that they are small
and inexpensive to maintain. However, wild type mice, i.e.
immuno-competent mice, such as A/J, BALB/c, C57BL/6
are only transiently permissible to DENV replication
[11-13]. A/J mouse showed a slight viremia on day 2
post DENV-2 injection, shown only by RT-PCR [12].
BALB/c showed an undetectable level of DENV-2 viremia,
which stands below the sensitivity assays for normal
virus titre and/or isolation [13]. Immuno-competent mice
exhibited peripheral viremia only when suckling wild-type
mice were injected with DENV intracranially [14]. Periph-
eral replication of DENV in mice was first reported in
either immuno-deficient or humanized mice [15-17].
Mice that have had their immunity disabled, such as
Interferon Regulatory Factor (IRF) 3/7 knock-out mice,
have been shown to support DENV-2 replication and to be
transmitted to mosquitoes [15]. Interferon (IFN) receptor-
deficient mice (AG129) lack the receptors for IFNα/β
and γ, permitting all four DENV serotypes to replicate
after peripheral inoculation [16]. Subcutaneous infection
of humanized NOD/SCID mice with low-passage dengue
human isolates also results in measurable viremia [17].
To date, dengue-vector transmission experiments have
been performed by direct intrathoracic inoculation of the
virus, artificial feeding technique, or using viremic animal
models, e.g., humans, suckling mice, or humanized mice
[14-20]. The disadvantages of utilizing direct inoculation
and membrane-feeding techniques are that both proce-
dures are time-consuming and laborious, especially for theproduction of large numbers of infected mosquitoes. The
techniques are also unnatural, as they do not involve
live animals. Newborn wild-type mice have been used
for transmission of dengue to vector, but they required
intracranial injection of high dose DENV at less than
24-hour-old [14]. Viremic humanized mice have also
been used for transmission of dengue to vector [20], but
maintenance of these animals requires extra resources.
Consequently, immuno-competent mice are the preferred
vessel for large transmission experiments, especially if
resources are limited.
In this paper, we develop a method to produce viremia
in immuno-competent mice. We were able to maintain
high virus concentration in the mice until at least 7 h
post-injection. Within this window period, we managed
to infect a large number of adult female mosquitoes
simultaneously from a single mouse host.
Methods
Materials
Ae. aegypti Liverpool Inbreeding (INB12) strain was
provided by Dr. Akio Mori, University of Notre Dame,
Indiana, USA. Five-week-old C3H mice were purchased
from Japan SLC, Japan. K562 erythroleukemia cells were
purchased from Dainippon Sumitomo Pharma, Japan. Vero
cell cultures were acquired from the American Type
Culture Collection (ATCC). DENV-2 ThNH7/93 strain was
kindly provided by Dr. Akira Igarashi from the Institute of
Tropical Medicine, Nagasaki University. Monoclonal anti-
body (mAb) against DENV-4 (D4-I-1D6) was obtained
from Dr. Eiji Konishi, Kobe University.
Cell infection with DENV-2 in the presence of mAb
against DENV-4
K562 erythroleukemia cells were grown in RPMI-1640
medium (Sigma-Aldrich) supplemented with 10% HyClone
(Thermo Scientific). Cells were cultured in a humidified
atmosphere containing 5% CO2 at 37°C until a density
of 1.5 × 107 cells/mL per aliquot was reached. The cells
then were infected with 1.5 × 107 PFU/ml DENV-2
ThNH7/93 (MOI 1.0). The suspension was supplemented
to 0.7 μg/ml with D4-I-1D6 mAb. After incubation for 2 h
in 5% CO2 at 37°C, the infected cells were collected by
brief centrifugation and re-suspended in RPMI-1640
supplemented with 10% HyClone and 0.7 μg/ml of D4-
I-1D6 mAb. The final suspension then was transferred
into filter-cap flasks and incubated in 5% CO2 at 37°C
for 2 d (Figure 1).
Mouse infection and blood collection
After 2 d of incubation, the suspension was centrifuged
briefly. The supernatant was removed and the pellet was
re-suspended in RPMI-1640 medium supplemented with
10% FBS and centrifuged a second time. The supernatant
Figure 1 DENV-2 infection of K562 cells. Prior to infection of mice and mosquitoes, DENV-2 is propagated in K562 cells at MOI 1.0 in the
presence of antibody against DENV-4. After incubation for 2 h in 37°C, cells are centrifuged, then resuspended in an equivalent volume of fresh
medium containing antibody against DENV-4. The mixture then is incubated for two days at 37°C.
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of serum-free RPMI-1640 medium and sub-divided into
four equal volumes. Using a 1-ml disposable syringe fitted
with an 18-G needle, each aliquot was aspirated into
syringe. Each aliquot of cell suspension was injected
intraperitoneally (via 22-G needle) into 5-week-old C3H
mice. Blood samples were collected at 4, 5, 6, and 7 hours
post-infection from the retro-orbital sinus according
to standard method [21] and then subjected to plaque
assay (below).
Mosquito infection and harvesting
Ae. aegypti Liverpool (INB12) strain was reared in a
controlled environment: temperature was 26 ± 1°C, rela-
tive humidity was 80–95%, and LD cycle of 16:8 was
maintained daily. Larvae were fed a combination of a
finely-ground mouse food (CLEA, Japan) and fish food
(Tetramin, Germany). Pupae were collected into plastic
cups until emergence. Emerged mosquitoes were trans-
ferred into a mesh-cage with unlimited access to 4% sugar
solution until 5–9 d old. Mosquitoes were not blood-fed
prior to experiment. The mosquitoes were given a chance
to feed from the infected mice at 5 h post-mouse infec-
tion. The mice were anesthetized and placed on top of the
cage. The mosquitoes were allowed to feed for 1 h; about
100–150 female mosquitoes fed from a mouse. After 1 h,
the mosquitoes were incubated in a 28°C incubator.
Mosquitoes were sacrificed 2, 6, 12, or 24 h post-feeding
by flash-freezing. The carcasses were kept at -80°C
prior to processing. The study was carried out in strictaccordance with the recommendations of The Committee
for Animal Experimentation, Oita University, at the P3
laboratory of the Oita University Animal Center.
Confirmation of infection
Confirmation of infection was performed using two me-
thods: plaque assay and reverse transcriptase polymerase
chain reaction (RT-PCR). In the plaque assay, four mos-
quitoes were randomly picked from each time point.
Mosquitoes were individually ground in 100 μl MEM
(Nissui) supplemented with 2% HyClone. The solution was
reserved as the undiluted (10°) inoculum. The supernatant
was diluted 101- to 106-fold and 100 μl of the diluted
supernatant was transferred into separate wells of 12-
well-plate (Corning) layered with confluent Vero cell
monolayers. After 1 h of incubation at 37°C in a 5% CO2
incubator, the infected monolayer was layered with 2%
methylcellulose and incubated again in 37°C, 5% CO2
incubator for 9 d. The gel-like solution was removed
after 9 d. The monolayer was fixed with formalin and
stained with 1.25% trypan blue. The plaques were counted
and the results were normalized as PFU per mosquito. To
check infectivity with RT-PCR, supernatant from ground
mosquitoes was first purified using RNeasy Mini Kit
(Qiagen). The purified RNA then was subjected to RT-
PCR using SuperScript III One-Step RT-PCR System
with Platinum Taq (Invitrogen) according to company’s
protocol [22] using previously published universal DENV
primers [23].
Figure 2 The measurement of DENV-2 concentration in infected
C3H mouse blood (A) dan early-stage infected mosquitoes (B).
DENV-2 titer from infected C3H mice (A). DENV-2 titer after virus
inoculation to mice intra-peritoneally using our technique. The
blood was obtained from the orbital sinus and subjected to plaque
assay. The result is the mean (±SE) of three different plaque assay
experiments for each time point. DENV-2 titer from early-stage-
infected mosquitoes (B). DENV-2 titer after oral virus administration
on mosquitoes using our technique. Mosquitoes were randomly
picked from a colony of 100–150 females and subjected to plaque
assay. The result is the mean (±SE) of three to four individual
mosquitoes for each time point.
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Difference in virus titers in the mice among each time
point were analyzed using repeated measures ANOVA
after log transformation. Virus titers in mosquitoes were
compared among each time point using one-way ANOVA
after log transformation [log (x + 1)]. Statistical analyses
were performed using the JMP 11.0.0 software package
(SAS Institute).Figure 3 RT-PCR of infected mosquitoes. DENV-2 confirmation of infecte
were infected, as shown by the existence of 500 bp band using RT-PCR. 2 hpi
24 hpi: 24 h post-infection, PC: positive control, NC: negative control.Results
Mass infection of Ae. aegypti is achievable
In order to achieve high levels of viremia sufficient to
cause infection of mosquitoes, an antibody was first used
to enhance virus replication within cells. This method
exploits the characteristic of dengue virus to enhance
replication in the presence of an antibody against different
serotypes. These infected cells were then injected into an
immuno-competent mouse, permitting the maintenance
of a high virus titer for at least 7 h post-injection and no
significant difference was observed among each time point
(Figure 2A; repeated measures ANOVA: d.f. = 3, F = 3.2,
P = 0.1.036). Within this time period, the mosquitoes were
allowed to feed from the viremic mouse. The virus was
viable and achieved a high titer in the mosquitoes’ bodies
except on 24 h post-feeding (Figure 2B; one-way ANOVA:
d.f. = 3, F = 8.6, P = 0.0049).
Most of the mosquitoes are infected
RT-PCR was used to confirm the infection. The RNAs
of three to four mosquitoes that were randomly picked
from each time point were purified using RNeasy Mini
Kit according to the company’s protocol. Using DENV-2
universal primers, RT-PCR gave 13 positive results out
of 14 tested samples, or 93% positive (Figure 3).
Discussion
Viremia is a feature required for dengue-vector transmis-
sion experiment. NHP and immuno-deficient mice have
been shown to easily display viremia, but the price, limited
accessibility, and reduced practicality of these animal
models make them less attractive. Consequently, immuno-
competent mice are the preferred vessels for transmission
experiments. Except for newborn mice, however, these mice
do not easily develop viremia post-dengue infection; hence
it is difficult to use these mice in simple transmission exper-
iments. Therefore, we have developed a method to orally
infect a large number of mosquitoes by means of viremic
adult immuno-competent mouse using a combination of
cultured cells, DENV, and monoclonal antibody.
Dengue virus is unique in that the antibody developed
due to exposure of the virus in vivo provides only a limited
interval of protection against other serotypes of virus.
Once the threshold is lower than a certain level, the
antibody binds to the different serotype of virus withd mosquitoes at various time points shows that 13 out of 14 mosquitoes
: 2 h post-infection, 6 hpi: 6 h post-infection, 12 hpi: 12 h post-infection,
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the virus is still viable for replication [24]. The virus
still gains access to monocytic cells via the Fc receptor
and propagates, causing enhancement of viremia. This
antibody-dependent enhancement is exploited in this
experiment. Yamanaka and Konishi showed that the
D4-I-1D6 monoclonal antibody enhance DENV-2 propa-
gation in K562 cells [25]. In the presence of the antibody,
nearly 100% of K562 cells were infected with DENV-2,
yielding a concentration of 1 × 107.2 FFU/ml, higher than
the concentration reached without any antibody. When
injected into an adult immuno-competent mouse, the
antibody also enhanced the yield of DENV-2 in the
periphery [26]. This is in contrast to mice that were
injected with DENV-infected cells cultured without
exogenous antibody; only very low level of circulating
virus were detected [13].
In accordance with Yamanaka and Konishi [26], our
infected C3H mice exhibited viremia 4–7 h post-
injection. This viremia was higher than what was
achieved with injection of DENV into IRF 3/7 knock-
out mice [15]. Our model yielded a mean of 1.04 × 105
PFU/ml (min. 4 × 104 PFU/ml, max. 2.64 × 105 PFU/ml),
while IRF 3/7 knock-out mice only yielded a mean
of 7.14 × 102 PFU/ml (min. 3.0 × 101 PFU/mL, max.
2.15 × 103 PFU/mL). The same injection technique
also worked with different adult immuno-competent
mouse type, such as ICR [26].
Contrary to injected virus into immuno-compromised
mice, the viremia reached in this technique is not due to
replication of DENV inside the mouse. The infected cells
leak the virus out into the mice’s bloodstream for at least
until 7 hours post-injection. By maintaining the viremia
at sufficient levels long enough for mosquitoes to acquire
the virus, we managed to infect a large number of Ae.
aegypti simultaneously by letting the mosquitoes to feed
blood directly for 1 h.
In the present work, the existence of DENV-2 in mos-
quitoes was confirmed both by plaque assay and RT-PCR.
Approximately 93% of tested mosquito samples in various
time frames were positive for DENV-2. Furthermore, the
concentration of DENV-2 in mosquitoes remained high at
least until 12 h post-acquisition, with a mean of 8.92 × 103
PFU/ml (min. 0, max. 2.64 × 104 PFU/ml).
Conclusions
We have developed a new technique to simultaneously
infect a large number of Ae. aegypti by means of viremic
immuno-compentent mouse. This new method simulates
the natural route of mosquito infection with dengue virus.
In this paper, we did not pursue the relationship between
virus concentration and post-injection time with the virus
concentration in mice or individual mosquitoes, issues
that will be the subjects of our future experiments.Competing interests
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